SEC Form D · filed January 17, 2024
Voyager Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (28)
Jude A. Onyia · Cambridge, MADirectorPeter Pfreundschuh · Cambridge, MAExecJacquelyn Fahey Sandell · Lexington, MAExecGlenn A. Pierce · Cambridge, MADirectorTodd Carter · Nashville, TNExecJames A. Geraghty · LONDON, United KingdomDirectorGrace A. Colon · Cambridge, MADirectorRobin Swartz · Lexington, MAExecRobin Swartz · Lexington, MAExecJude A. Onyia · Cambridge, MADirectorGeorge A. Scangos · South San Francisco, CADirectorGeorge A. Scangos · Lexington, MADirectorNancy A. Vitale · Cambridge, MADirectorCatherine A. Mackey · Cambridge, MADirectorPeter Pfreundschuh · Cambridge, MAExecSteven A. Hyman · Cambridge, MADirectorAlfred Sandrock · CAMBRIDGE, MAExec · DirectorNancy A. Vitale · Cambridge, MADirectorSteven A. Hyman · Cambridge, MADirectorJames A. Geraghty · Cambridge, MADirectorMichael Higgins · London, United KingdomDirectorAlfred Sandrock · CAMBRIDGE, MAExec · DirectorJacquelyn Fahey Sandell · Lexington, MAExecGrace A. Colon · Cambridge, MADirectorTodd Carter · Nashville, TNExecMichael Higgins · HOUSTON, TXDirectorGlenn A. Pierce · Cambridge, MADirectorCatherine A. Mackey · Cambridge, MADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗